Navigation Links
PharmSource Lead Sheet Adds Coverage of Medical Devices and Diagnostics
Date:12/12/2012

Fairfax, VA (PRWEB) December 11, 2012

PharmSource Information Services, Inc. (PharmSource) has announced that it now offers a concise data-driven resource that delivers targeted business opportunities to companies supporting the medical device/diagnostic arena, worldwide.

This offering, known as the PharmSource Lead Sheet: Devices & Diagnostics Edition, provides pipeline updates regarding medical device and diagnostic candidates in the clinical trial process, as well as approvals and clearances in the US and abroad. Weekly updates signal when medical devices or diagnostics move into a new development stage. Product coverage includes pre-feasibility through post-marketing, acquisitions and alliances. In addition, users are informed company acquisitions and alliances, corporate-level financings and other deals and events that signal corporate expansions or contractions.

The availability of a weekly supply of fresh intelligence on the medical device and diagnostic world in this single-source, user-friendly resource is expected to be a major boon for CROs, CMOs and other companies providing services in this industry.

This resource enables service providers to easily identify new opportunities based on criteria that are relevant to specific needs (i.e., therapeutic specialty; device/diagnostic purpose or type; approval status; class; lifespan; invasiveness; material; and more). Hotlinks go immediately to deeper information about both the product and the company. In addition, verified contacts are provided for each company reported in the weekly report to help business development teams start calls at the right level.

For a limited time, PharmSource is offering a complimentary walk-through of the PharmSource Lead Sheet: Devices & Diagnostics Edition for qualified companies. For more information, contact PharmSource directly at 1-703-383-4903, ext. 112 / info(at)pharmsource(dot)com.

About PharmSource®
PharmSource specializes in bringing together buyers and sellers of contract services related to drug development and manufacturing. Founded in 1996, this globally respected provider of proprietary databases and insightful market intelligence serves clients’ strategic information needs and helps them to be aware of and fully understand critical sourcing factors and make optimal operating and strategic decisions. To learn more, visit PharmSource at http://www.pharmsource.com, or contact info(at)pharmsource(dot)com / phone: 1-703-383-4903 (USA, eastern time-zone).

Read the full story at http://www.prweb.com/releases/PharmSource/Dec2012/prweb10194466.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Northwest Bio Implements Major Balance Sheet Clean-Up
2. UMass Amherst polymer scientists, physicists develop new way to shape thin gel sheets
3. Simple, cheap way to mass-produce graphene nanosheets
4. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
5. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
6. A New Dawn in Cosmetics Coverage: Cosmetics Design Launches Asia-Pacific News Website
7. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
8. DiaTech Life Sciences Announces Medical Advisory Board
9. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
10. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
11. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , Jan. 20, 2017 Ginkgo Bioworks, ... Gen9, a pioneer in the synthesis and assembly ... expertise in assembling pathway-length synthetic DNA into Ginkgo,s ... capacity in the construction of new organism designs ... "Gen9 was founded to significantly increase ...
(Date:1/20/2017)... (PRWEB) , ... January 20, ... ... in Less Exposure Surgery (LES®) Technologies, announced today the next evolution in ... Pedicle Screw System platform). In contrast to the competition, SpineFrontier is focused ...
(Date:1/19/2017)... , Jan. 19, 2017  Market Research Future has a ... Market for Liquid Biopsy is growing rapidly and expected to reach ... Market Highlights ... The Global Liquid Biopsy Market has been assessed as a swiftly ... figures and boom in the coming future. There has been a ...
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
Breaking Biology Technology:
(Date:1/18/2017)... 2017  In vitro diagnostic (IVD) companies were very ... (M&A), and Kalorama Information expects that trend to continue ... shifting. Generally, uncertainty in reimbursement and healthcare reform in ... changed the acquisitions landscape. Instead of looking to buy ... partners outside of their home country and also to ...
(Date:1/12/2017)... research undertaken by Fit Small Business has revealed ... simply asked which office technology had they not used in ... Insights on what will be key features in ... industry leaders including Penelope Trunk , Martin Lindstrom ... Some of these findings included; ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
Breaking Biology News(10 mins):